{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:08Z","timestamp":1761897008445,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.acuro.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T17:17:59Z","timestamp":1558113479000},"page":"337-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An\u00e1lisis del escenario microsc\u00f3pico de una biopsia prost\u00e1tica negativa como predictor del riesgo de c\u00e1ncer de pr\u00f3stata. Una revisi\u00f3n sistem\u00e1tica"],"prefix":"10.1016","volume":"43","author":[{"given":"I.","family":"Schwartzmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Celma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Regis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Placer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Trilla Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Morote Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2019.01.010_bib0290","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.acuro.2019.01.010_bib0295","first-page":"1377","article-title":"Prostate cancer screening: The continuing controversy","volume":"78","author":"Wilbur","year":"2008","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.acuro.2019.01.010_bib0300","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2011.01.075","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"De la Taille","year":"2011","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0305","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.acuro.2019.01.010_bib0310","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.28349","article-title":"Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study","volume":"120","author":"Moreira","year":"2014","journal-title":"Cancer."},{"key":"10.1016\/j.acuro.2019.01.010_bib0315","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.medcli.2010.01.015","article-title":"Declaraci\u00f3n PRISMA: una propuesta para mejorar la publicaci\u00f3n de revisiones sistem\u00e1ticas y metaan\u00e1lisis","volume":"135","author":"Urr\u00fatia","year":"2010","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.acuro.2019.01.010_bib0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/pcan.2015.14","article-title":"Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation","volume":"18","author":"Warlick","year":"2015","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuro.2019.01.010_bib0325","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/pros.22950","article-title":"Prostate atypia: Does repeat biopsy detect clinically significant prostate cancer?","volume":"75","author":"Dorin","year":"2015","journal-title":"Prostate."},{"key":"10.1016\/j.acuro.2019.01.010_bib0330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1590\/S1677-5538.IBJU.2014.05.04","article-title":"How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?","volume":"40","author":"Aglamis","year":"2014","journal-title":"Int Braz J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0335","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.juro.2010.11.063","article-title":"A model to predict prostate cancer after atypical findings in initial prostate needle biopsy","volume":"185","author":"Merrimen","year":"2011","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0340","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000137637","article-title":"Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?","volume":"81","author":"Mearini","year":"2008","journal-title":"Urol Int."},{"key":"10.1016\/j.acuro.2019.01.010_bib0345","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4111\/kju.2015.56.12.796","article-title":"Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy","volume":"56","author":"Kim","year":"2015","journal-title":"Korean J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0350","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2010.09.035","article-title":"Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer","volume":"46","author":"Laurila","year":"2010","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.acuro.2019.01.010_bib0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/pcan.2015.52","article-title":"Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review","volume":"19","author":"Leone","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuro.2019.01.010_bib0360","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00345-009-0413-1","article-title":"High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: Incidence and implications for patient care and surveillance","volume":"27","author":"Ploussard","year":"2009","journal-title":"World J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0365","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0210-4806(08)73914-7","article-title":"[Clinical significance of prostatic intraepithelial neoplasm and atypical small acinar proliferation: relationship with prostate cancer]","volume":"32","author":"Pascual Mateo","year":"2008","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuro.2019.01.010_bib0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2490-9-3","article-title":"Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: A UK hospital experience","volume":"9","author":"Singh","year":"2009","journal-title":"BMC Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0375","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.juro.2010.06.137","article-title":"Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer","volume":"184","author":"Lee","year":"2010","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0380","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1464-410X.2011.10532.x","article-title":"Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: Proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy","volume":"109","author":"Roscigno","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2019.01.010_bib0385","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/pcan.2011.3","article-title":"Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: A study on 546 patients","volume":"14","author":"Antonelli","year":"2011","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuro.2019.01.010_bib0390","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.humpath.2010.09.006","article-title":"Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?","volume":"42","author":"Hailemariam","year":"2011","journal-title":"Hum Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0395","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.urology.2010.07.519","article-title":"Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy","volume":"77","author":"Godoy","year":"2011","journal-title":"Urology."},{"key":"10.1016\/j.acuro.2019.01.010_bib0400","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1111\/j.1464-410X.2012.11557.x","article-title":"Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPIN","volume":"110","author":"He","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2019.01.010_bib0405","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/modpathol.2012.51","article-title":"Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer","volume":"25","author":"Kryvenko","year":"2012","journal-title":"Mod Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4081\/aiua.2013.2.59","article-title":"Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies","volume":"85","author":"De Nunzio","year":"2013","journal-title":"Arch Ital Urol Androl."},{"key":"10.1016\/j.acuro.2019.01.010_bib0415","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12885-016-2085-8","article-title":"Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: Results from a multicenter biopsy study","volume":"16","author":"Cicione","year":"2016","journal-title":"BMC Cancer."},{"key":"10.1016\/j.acuro.2019.01.010_bib0420","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1111\/j.1464-410X.2011.10876.x","article-title":"Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia","volume":"110","author":"Garcia-Cruz","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2019.01.010_bib0425","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5173\/ceju.2014.02.art4","article-title":"Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice","volume":"67","author":"Adamczyk","year":"2014","journal-title":"Cent Eur J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0430","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2015.05.103","article-title":"Baseline prostate atrophy is associated with reduced risk of prostate cancer in men undergoing repeat prostate biopsy","volume":"194","author":"Moreira","year":"2015","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0435","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bju.12153","article-title":"Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial","volume":"112","author":"Yli-Hemminki","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2019.01.010_bib0440","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pros.23234","article-title":"Clinical significance of proliferative inflammatory atrophy in negative prostatic biopsies","volume":"76","author":"Servian","year":"2016","journal-title":"Prostate."},{"key":"10.1016\/j.acuro.2019.01.010_bib0445","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.urolonc.2010.01.010","article-title":"Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma","volume":"29","author":"Asimakopoulos","year":"2011","journal-title":"Urol Oncol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0450","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11255-015-1029-6","article-title":"Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?","volume":"47","author":"Yun","year":"2015","journal-title":"Int Urol Nephrol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1464-410X.2007.07267.x","article-title":"Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?","volume":"101","author":"Wolters","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2019.01.010_bib0460","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/apm.12291","article-title":"Histopathological screening for prostate carcinoma: Is a benign biopsy a negative biopsy?","volume":"122","author":"Sailer","year":"2014","journal-title":"APMIS."},{"key":"10.1016\/j.acuro.2019.01.010_bib0465","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/01.ju.0000134622.54235.93","article-title":"Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?","volume":"172","author":"Brausi","year":"2004","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0470","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.eururo.2006.07.048","article-title":"Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies. (Also referred to as \u201cAtypical Small Acinar Proliferation Suspicious for but not Diagnostic of Malignancy\u201d)","volume":"50","author":"Montironi","year":"2006","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0475","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1309\/AJCP5UNFIVER0LTV","article-title":"Improved resolution of diagnostic problems in selected prostate needle biopsy specimens by using the ASAP Workup","volume":"134","author":"Strand","year":"2010","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0480","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0485","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.acuro.2013.10.001","article-title":"Current significance of the finding of high grade prostatic intraepithelial neoplasia in the prostate biopsy","volume":"38","author":"Bastar\u00f3s","year":"2014","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuro.2019.01.010_bib0490","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2559.2011.04007.x","article-title":"Precursors of prostate cancer","volume":"60","author":"Bostwick","year":"2012","journal-title":"Histopathology."},{"key":"10.1016\/j.acuro.2019.01.010_bib0495","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/pros.22995","article-title":"Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia","volume":"75","author":"Sequeiros","year":"2015","journal-title":"Prostate."},{"key":"10.1016\/j.acuro.2019.01.010_bib0500","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.mri.2016.05.006","article-title":"Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy","volume":"34","author":"Dwivedi","year":"2016","journal-title":"Magn Reson Imaging."},{"key":"10.1016\/j.acuro.2019.01.010_bib0505","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.urolonc.2009.07.033","article-title":"Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci","volume":"29","author":"Sciarra","year":"2011","journal-title":"Urol Oncol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0510","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.pas.0000213289.50660.be","article-title":"A working group classification of focal prostate atrophy lesions","volume":"30","author":"De Marzo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.acuro.2019.01.010_bib0515","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S1677-55382010000400003","article-title":"Prostatic atrophy. Clinicopathological significance","volume":"36","author":"Billis","year":"2010","journal-title":"Int Braz J Urol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0520","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00000478-199809000-00005","article-title":"Histology and cellular kinetics of prostatic atrophy","volume":"22","author":"Ruska","year":"1998","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0525","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1439-0272.2007.00831.x","article-title":"Proliferative inflammatory atrophy: A background lesion of prostate cancer?","volume":"40","author":"Woenckhaus","year":"2008","journal-title":"Andrologia."},{"key":"10.1016\/j.acuro.2019.01.010_bib0530","series-title":"Prostate cancer. Science and clinical practice","first-page":"13","article-title":"Inflammation and infection in the etiology of prostate cancer","author":"Sutcliffe","year":"2015"},{"key":"10.1016\/j.acuro.2019.01.010_bib0535","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2013.07.041","article-title":"Prostatic atrophy: Its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides","volume":"45","author":"Iczkowski","year":"2014","journal-title":"Hum Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0540","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/pros.20992","article-title":"Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate","volume":"69","author":"Wang","year":"2009","journal-title":"Prostate."},{"key":"10.1016\/j.acuro.2019.01.010_bib0545","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3892\/ijo.2012.1646","article-title":"Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients","volume":"41","author":"Vral","year":"2012","journal-title":"Int J Oncol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0550","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.acuro.2019.01.010_bib0555","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0090-4295(02)01637-0","article-title":"Epidemiologic association between prostatitis and prostate cancer","volume":"60","author":"Dennis","year":"2002","journal-title":"Urology."},{"key":"10.1016\/j.acuro.2019.01.010_bib0560","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/pcan.2015.66","article-title":"Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: Results from the REDUCE study","volume":"19","author":"Moreira","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuro.2019.01.010_bib0565","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.anndiagpath.2016.04.010","article-title":"Inflammation and focal atrophy in prostate needle biopsy cores and association to prostatic adenocarcinoma","volume":"24","author":"Benedetti","year":"2016","journal-title":"Ann Diagn Pathol."},{"key":"10.1016\/j.acuro.2019.01.010_bib0570","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.urology.2016.05.015","article-title":"The effect of a pure anti-inflammatory therapy on reducing prostate-specific antigen levels in patients diagnosed with a histologic prostatitis","volume":"94","author":"Gallo","year":"2016","journal-title":"Urology."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480619300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480619300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:36:07Z","timestamp":1759322167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480619300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0210480619300683"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2019.01.010","relation":{},"ISSN":["0210-4806"],"issn-type":[{"type":"print","value":"0210-4806"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e1lisis del escenario microsc\u00f3pico de una biopsia prost\u00e1tica negativa como predictor del riesgo de c\u00e1ncer de pr\u00f3stata. Una revisi\u00f3n sistem\u00e1tica","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}